Medical Journals

Tumor Growth Impedes Natural-killer-cell Maturation in the Bone Marrow.

Authors:
  • Richards John O
  • Chang Xing
  • Blaser Bradley W
  • Caligiuri Michael A
  • Zheng Pan
  • Liu Yang

From: Division of Cancer Immunology, Department of Pathology, The Ohio State University Medical Center and Comprehensive Cancer Center, Columbus, OH 43210, USA.

Blood

  • Publish Date: Jul 2006
  • ISSN: 0006-4971
  • Volume: 108
  • Issue: 1
  • Pages: 246-52
  • Medium: Print
  • Language: English
  • Citation (JAMA): Richards John O, Chang Xing, Blaser Bradley W, et al. Tumor Growth Impedes Natural-killer-cell Maturation in the Bone Marrow.. Blood Jul 2006;108:246-52

Abstract

Natural-killer (NK)-cell dysfunction and IFN-gamma deficiencies have been associated with increased incidence of both malignancy and infection. The immunologic basis of NK-cell defects in cancer-bearing hosts has not been extensively studied. Here, we demonstrate that multiple lineages of tumors, including thymoma, breast cancer, colon cancer, and melanoma cell lines, interrupt functional maturation during NK-cell development in the bone marrow. The immature NK cells in the periphery of tumor-bearing mice had impaired IFN-gamma production but seemingly normal cytotoxicity. T cells are not involved in this NK maturation arrest, because T-cell depletion did not restore NK-cell development. Moreover, the extent of tumor-cell infiltration into the bone marrow does not correlate with defective NK maturation. Interestingly, the defect was associated with a significant reduction in the IL-15Ralpha+ cells in the non-T, non-NK compartment of bone marrow cells and restored by overexpression of IL-15. Our data demonstrate that tumor growth can impede functional maturation of NK cells, most likely by interrupting the requisite IL-15 signaling pathway.

Mesh Headings (Keywords): Animals, Bone Marrow, Cell Differentiation, Cell Line, Tumor, Cytotoxicity, Immunologic, Humans, Interferon Type II, Interleukin-15, Killer Cells, Natural, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasm Transplantation, Neoplasms, Tumor Escape, Xenograft Model Antitumor Assays


Check for Full Text / PubMed Unique Identifier (PMID): 16556890


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.